Investment Analysts’ Recent Ratings Changes for Aflac (AFL)

Several brokerages have updated their recommendations and price targets on shares of Aflac (NYSE: AFL) in the last few weeks:

• 8/15/2026 – Aflac was downgraded by Wall Street Zen from “hold” to “sell”.
• 8/11/2026 – Aflac had its price target lowered by JPMorgan Chase & Co. from $117.00 to $116.00. They now have a “neutral” rating on the stock.
• 8/11/2026 – Aflac had its price target raised by Keefe, Bruyette & Woods from $120.00 to $125.00. They now have a “market perform” rating on the stock.
• 8/10/2026 – Aflac had its “overweight” rating reaffirmed by Piper Sandler. They now have a $138.00 price target on the stock, up from $130.00.
• 8/10/2026 – Aflac was given a new $116.00 price target by Mizuho.
• 8/7/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 8/7/2026 – Aflac had its “underweight” rating reaffirmed by Barclays PLC. They now have a $99.00 price target on the stock, up from $98.00.
• 7/23/2026 – Aflac was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.
• 7/22/2026 – Aflac had its “hold” rating reaffirmed by TD Cowen. They now have a $110.00 price target on the stock, up from $101.00.
• 7/21/2026 – Aflac had its price target raised by JPMorgan Chase & Co. from $108.00 to $117.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – Aflac had its price target raised by Keefe, Bruyette & Woods from $115.00 to $120.00. They now have a “market perform” rating on the stock.
• 7/10/2026 – Aflac had its “hold” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $108.00 price target on the stock, up from $100.00.
• 7/9/2026 – Aflac was given a new $112.00 price target by Mizuho.
• 7/9/2026 – Aflac had its price target raised by Wells Fargo & Company from $111.00 to $120.00. They now have an “equal weight” rating on the stock.
• 7/8/2026 – Aflac had its “neutral” rating reaffirmed by UBS Group AG. They now have a $124.00 price target on the stock, up from $114.00.
• 7/7/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 7/7/2026 – Aflac had its price target lowered by Barclays PLC from $99.00 to $98.00. They now have an “underweight” rating on the stock.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Wednesday, August 19th will be paid a $0.61 dividend. The ex-dividend date of this dividend is Wednesday, August 19th. This represents a $2.44 dividend on an annualized basis and a yield of 2.0%. Aflac’s dividend payout ratio (DPR) is currently 26.15%.

Insider Buying and Selling at Aflac

In other news, major shareholder Post Holdings Co. Ltd. Japan sold 13,000 shares of Aflac stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $121.09, for a total transaction of $1,574,170.00. Following the transaction, the insider owned 50,872,690 shares in the company, valued at approximately $6,160,174,032.10. The trade was a 0.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph L. Moskowitz sold 600 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $124.10, for a total value of $74,460.00. Following the transaction, the director directly owned 32,710 shares in the company, valued at $4,059,311. The trade was a 1.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 591,333 shares of company stock worth $69,285,006. Company insiders own 0.80% of the company’s stock.

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.